
🔐 Secure Payment Guaranteed
Safe checkout with trusted global payment methods.
🌟 Why Choose Infinity Market Research?
At Infinity Market Research, we dont just deliver data — we deliver clarity, confidence, and competitive edge.
In a world driven by insights, we help businesses unlock the infinite potential of informed decisions.
Here why global brands, startups, and decision-makers choose us:
Industry-Centric Expertise
With deep domain knowledge across sectors — from healthcare and technology to manufacturing and consumer goods — our team delivers insights that matter.
Custom Research, Not Cookie-Cutter Reports
Every business is unique, and so are its challenges. Thats why we tailor our research to your specific goals, offering solutions that are actionable, relevant, and reliable.
Data You Can Trust
Our research methodology is rigorous, transparent, and validated at every step. We believe in delivering not just numbers, but numbers that drive real impact.
Client-Centric Approach
Your success is our priority. From first contact to final delivery, our team is responsive, collaborative, and committed to your goals — because you re more than a client; you re a partner.
Recent Reports
Laboratory Degassers Market
Laboratory Funnel Market
Global Crysvita Injection Market Growth 2025-2031
Sep 2025
Healthcare
Pages: 76
LPI9971
The global Crysvita Injection market size is predicted to grow from US$ 72.6 million in 2025 to US$ 88.9 million in 2031; it is expected to grow at a CAGR of 3.4% from 2025 to 2031.
X-linked hypophosphatemia, or XLH, is a hereditary skeletal disease triggered by excess production of the hormone fibroblast growth factor 23. FGF23 causes phosphate urinary excretion and hinders patients ability to produce vitamin D. CRYSVITA is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 6 months of age and older.
Brosumab (burosumab, trade name Crysvita) is a recombinant fully humanized monoclonal IgG1 antibody targeting fibroblast growth factor 23 (FGF23) jointly developed by Ultragenyx Pharmaceutical and Kyowa Hakko Kirin. In February 2018, the drug was conditionally approved by the European Union for the treatment of X-linked hypophosphatemia (XLH) in children and adults aged 1 and above, becoming the worlds first XLH treatment drug, and it was approved by the FDA in April of the same year indications. In September of the following year, the drug was approved by the FDA to expand the indication population to infants as young as 6 months old. FGF23 is a bone-derived hormone that regulates the metabolism of phosphorus and vitamin D. It can block the reabsorption of phosphate by the kidney and inhibit the absorption of vitamin D-dependent phosphate, resulting in a significant decrease in the level of phosphate in the blood. It is XLH main culprit. XLH is a rare genetic disorder and the most common form of hypophosphatemic rickets, affecting 1 in 20,000 people. XLH is carried on the X chromosome, and while nearly all X-linked disorders are recessive, XLH is one of the few that is inherited in a dominant manner.
Infinity Market Research newest research report, the ?Crysvita Injection Industry Forecast? looks at past sales and reviews total world Crysvita Injection sales in 2024, providing a comprehensive analysis by region and market sector of projected Crysvita Injection sales for 2025 through 2031. With Crysvita Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Crysvita Injection industry.
This Insight Report provides a comprehensive analysis of the global Crysvita Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Crysvita Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Crysvita Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Crysvita Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Crysvita Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Crysvita Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
10 mg/mL
20 mg/mL
30 mg/mL
Segmentation by Application:
Children
Adults
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.
Kyowa Kirin
Ultragenyx Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Crysvita Injection market?
What factors are driving Crysvita Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Crysvita Injection market opportunities vary by end market size?
How does Crysvita Injection break out by Type, by Application?
Crysvita Injection Market Scope
Report Attribute | Details |
---|---|
Market Size (Start Year) | USD XX Million |
Market Size (End Year) | USD XX Million |
Compound Annual Growth Rate (CAGR) | USD XX Million |
Forecast Period | USD XX Million |
Base Year | USD XX Million |
Historical Data | USD XX Million |
Key Players | USD XX Million |
📘 Frequently Asked Questions
1. What is the market size of Global Crysvita Injection Market?
Answer: The global Crysvita Injection market size is predicted to grow from US$ 72.6 million in 2025 to US$ 88.9 million in 2031; it is expected to grow at a CAGR of 3.4% from 2025 to 2031.
2. Which regions are analyzed in the Global Crysvita Injection Market report?
Answer: The Global Crysvita Injection Market report covers major regions such as Europe, Middle East & Africa. Each region is analyzed for trends, opportunities, and market dynamics.
3. What methodology is used for forecasting of Global Crysvita Injection Market?
Answer: The Global Crysvita Injection Market report uses a mix of primary research, secondary data, and expert analysis to build its forecasts. Models include both qualitative and quantitative approaches.
4. Are emerging markets analyzed separately in the Global Crysvita Injection Market?
Answer: Yes, the Global Crysvita Injection Market report highlights high-growth emerging regions with dedicated insights. These include untapped opportunities, risks, and potential for expansion.
5. Does the report include competitive benchmarking of Global Crysvita Injection Market?
Answer: Yes, Global Crysvita Injection Market report compares major players based on revenue, product portfolio, innovation, and regional presence. This helps assess competitive positioning.
6. Can I access country-level data within the Global Crysvita Injection Market report?
Answer: Yes, Global Crysvita Injection Market report includes detailed data by country, especially for key markets. This allows for localized insights and decision-making.
7. Can I get customized insights or data from the Global Crysvita Injection Market report?
Answer: Yes, we offer customization options to align with your specific business needs. You can request tailored sections or regional breakdowns.
🎁 This Month Only: Flat $1000 OFF
Enjoy an exclusive $1000 discount on every report purchased this month. No code needed.

🔐 Secure Payment Guaranteed
Safe checkout with trusted global payment methods.
🌟 Why Choose Infinity Market Research?
- Accurate & Verified Data:Our insights are trusted by global brands and Fortune 500 companies.
- Complete Transparency:No hidden fees, locked content, or misleading claims — ever.
- 24/7 Analyst Support:Our expert team is always available to help you make smarter decisions.
- Instant Savings:Enjoy a flat $1000 OFF on every report.
- Fast & Reliable Delivery:Get your report delivered within 5 working days, guaranteed.
- Tailored Insights:Customized research that fits your industry and specific goals.
📄 Available License Types
